SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
Frank J. Lin(Washington University in St. Louis), Brian J. Laidlaw(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Ali H. Ellebedy(Washington University in St. Louis), Fang Zhao(Washington University in St. Louis), Laura A. VanBlargan(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Chieh-Yu Liang(Washington University in St. Louis), Philip A. Mudd(Washington University in St. Louis), Alexa Michelle Altman Doss(Washington University in St. Louis), Rita E. Chen(Washington University in St. Louis), Ofer Zimmerman(Washington University in St. Louis), Tiffany Biason Dy(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Zhen Ren(Washington University in St. Louis), Hannah G. Davis-Adams(Washington University in St. Louis), Peggy L. Kendall(Washington University in St. Louis), Caitlin C. O’Shaughnessy(Washington University in St. Louis), Christopher H. Hanson(Washington University in St. Louis), H. James Wedner(Washington University in St. Louis), Anthony Kulczycki(Washington University in St. Louis), Christopher J. Rigell(Washington University in St. Louis), Lucas J. Adams(Washington University in St. Louis), Elise Rizzi(Washington University in St. Louis), Saravanan Raju(Washington University in St. Louis), Andrew L. Kau(Washington University in St. Louis), Tarisa L. Mantia(Washington University in St. Louis), Michael S. Diamond(Washington University in St. Louis), Jennifer Monroy(Washington University in St. Louis)
Cited by 10
Related Papers
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851